GlassScriptPhysician profile
Robert George Weiss
NPI 1851337083
$361.98
in general payments reported to CMS, 2019-2025
8 companies · $87.39 in 2025
The $87.39 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.47 · 2023: $99.61 · 2024: $153 · 2025: $87.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $116.68 | 2024 | Daxxify |
| Janssen Biotech, INC. | $112.89 | 2023-2024 | Simponi, Simponi Aria, Stelara |
| Pfizer INC. | $36.09 | 2025 | |
| Leo Pharma INC. | $30.09 | 2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.55 | 2023 | Arazlo |
| Abbvie INC. | $22.47 | 2022 | |
| Biofrontera INC. | $21.21 | 2025 | Bf-Rhodoled |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.